EVALUATION OF EFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C, CAUSED BY HCV GENOTYPE 6

QR Code

EVALUATION OF EFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C, CAUSED BY HCV GENOTYPE 6

Objectives: Evaluating the effectiveness of 2 therapeutic schemes for chronic hepatitis C (genotype 6) which combined sofosbuvir and ribavirin, one of them also included pegylated interferon. Materials and methods: The study included 110 patients with chronic hepatitis C (genotype 6), who have under...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. A. Lioznov, N. H. Chung, S. L. Nikolaenko, T. B. Trung, F. T. Lan, N. D. Phong
Format:	Article
Language:	Russian
Published:	Journal Infectology 2017-04-01
Series:	Журнал инфектологии
Subjects:	chronic hepatitis c genotype 6 treatment sofosbuvir vietnam
Online Access:	https://journal.niidi.ru/jofin/article/view/566
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CLINICAL AND LABORATORY CHARACTERISTICS OF CHRONIC HEPATITIS C IN VIETNAM ON THE EXAMPLE OF HO CHI MINH CITY HEPATOLOGY CLINIC
by: D. A. Lioznov, et al.
Published: (2016-12-01)

Effects of antiviral therapy on reducing the risk of metabolic syndrome in patients with chronic hepatitis C
by: A. F. Novikova, et al.
Published: (2023-07-01)

Real-World Treatment Efficacy and Safety Profile of Sofosbuvir- and Velpatasvir-Based HCV Treatment in South Korea: Multicenter Prospective Study
by: Jae Hyun Yoon, et al.
Published: (2025-07-01)

Effectiveness and safety of sofosbuvir/velpatasvir in chronic hepatitis C virus infection of Bangladeshi children
by: Salahuddin Mahmud, et al.
Published: (2025-06-01)

Evaluation of Treatment Response in Chronic Hepatitis C Patients Receiving Sofosbuvir/Velpatasvir/Voxilaprevir: A Multicenter Real-World Experience from Türkiye
by: Umut Devrim Binay, et al.
Published: (2025-06-01)

Variety of genotypes of a HCV virus and outcomes of chronic hepatitis C: results 5 summer supervision in the territory of the Kirov region
by: S. V. Baramzina, et al.
Published: (2014-09-01)

Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg
by: D. A. Gusev, et al.
Published: (2023-01-01)

HCV Infection in the Republic of Sakha (Yakutia) and Its Role of Genotypes in Clinical Outcomes of the Disease
by: V. K. Semenova, et al.
Published: (2020-09-01)

Reconstruction of recombination sites in genomic structures of the strains of genotype 6 of hepatitis C virus
by: N. E. Garashchenko, et al.
Published: (2016-09-01)

Cost-effectiveness of antiviral therapy in treatment-naive patients with chronic hepatitis C (genotype 1)
by: A. V. Rudakova, et al.
Published: (2017-06-01)

Efficacy and safety of sofosbuvir plus daclatasvir in hemodialysis patients with genotype 1b or 2a hepatitis C virus infection: a single-arm, prospective real-world study
by: Kaili Wang, et al.
Published: (2025-07-01)

Genotypic Diversity of Hepatitis C Virus in Tuberculosis Patients in the Tomsk Region
by: K. A. Svirin, et al.
Published: (2025-03-01)

Genotypes and Subtypes of Hepatitis B Virus Isolates in the Territory of Siberia
by: G. V. Kochneva, et al.
Published: (2011-06-01)

COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C (GENOTYPE 1) WITH VARIOUS SEVERITY OF FIBROSIS STAGE
by: A. V. Rudakova, et al.
Published: (2018-01-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Cost-effectiveness of antiviral therapy in chronic hepatitis C (G1)
by: A. V. Rudakova, et al.
Published: (2016-02-01)

Enteric viral hepatitis in the Socialist Republic of Vietnam (Southern Vietnam)
by: Yu. V. Ostankova, et al.
Published: (2021-12-01)

Study on the Impacts of Haemoglobin Genotype on Hepatitis B vaccine Response among Vaccinated Individuals within Bauchi State, Nigeria
by: Thomas, K. M., et al.
Published: (2025-06-01)

Experience of effective antiviral therapy in a liver recipient with recurrent HCV infection genotype 1
by: D. V. Umrik, et al.
Published: (2019-01-01)

Eradication of hepatitits C virus in patient with cryoglobulinemic vasculitis and mutations D168E, L31V
by: N. V. Dunaeva, et al.
Published: (2020-03-01)

Peculiarity of Clinical Course of Childhood Hepatitis C Depending on the Viral Genotype
by: E. A. Leybman, et al.
Published: (2015-02-01)

DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR
by: Syed Hassan Murtaza, et al.
Published: (2024-03-01)

Chronic Hepatitis С in Siberian Federal District: Analysis of a Case Rate and Evolution of Genotypes of the Originator
by: E. D. Savilov, et al.
Published: (2018-09-01)

Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry
by: Tyng-Yuan Jang, et al.
Published: (2025-08-01)

Genetic variants of hepatitis B virus in patients with chronic hepatitis B
by: E. A. Elpaeva, et al.
Published: (2015-11-01)

Identification of the Recently Described Avian Hepatitis E Genotype 7 in an Outbreak of Hepatitis-Splenomegaly Syndrome (HSS) with High Mortality and Severe Drop in Egg Production in a Parent Stock Flock in Bangladesh
by: Miguel Matos, et al.
Published: (2025-04-01)

Liver cirrhosis as a result of chronic hepatitis C
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Efficacy and safety of сepeginterferon alfa-2b in double treatment regimen (cepeginterferon alfa-2b and ribavirin) of antiviral therapy in patients with chronic hepatitis C genotypes 2 and 3. Experience of real clinical practice
by: A. I. Pavlov, et al.
Published: (2016-11-01)

Treatment of chronic hepatitis С (genotype 6) in patients with contraindications to interferon-α
by: D. A. Lioznov, et al.
Published: (2016-02-01)

Antiviral therapy of hepatitis C with 1 genotype after liver transplantation
by: O. M. Tsiroulnikova, et al.
Published: (2018-09-01)

Characteristics of HCV infection in oncohematological patients
by: D. A. Lioznov, et al.
Published: (2020-03-01)

Characteristics of Hepatitis C Epidemic Process in the Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2021-01-01)

The incidence of chronic viral hepatitis and the analysis of the genetic diversity of hepatitis B and C viruses among the population of Khabarovsk city
by: Valeriya O. Kotova, et al.
Published: (2025-03-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

Variety of the hepatitis B virus genovariants in the military
by: Yu. V. Ostankova, et al.
Published: (2019-10-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Effectiveness and safety of narlaprevir in real clinical practice of chronic hepatitis C
by: V. V. Basina, et al.
Published: (2019-12-01)

Clinical and immunomorphological predictors of the adverse course of chronic hepatitis C
by: I. A. Karabak, et al.
Published: (2020-06-01)

For the question about Molecular Epidemiology of Hepatitis B Virus Infection in the Republic Sakha (Yakutia)
by: A. V. Semenov, et al.
Published: (2016-04-01)